Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confors: Teriparatide and Antiresorptive Combination in Osteoporosis
NCT01535027Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alendronate, raloxifene in osteoporosis, sponsored by Medical University of Vienna. Started Mar 2006; status: completed.
02
Drugs
alendronateraloxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01535027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535027.